The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl)benzyl)-3-(3,4-dihydroxyphenethyl)urea ID: ALA4858508
Chembl Id: CHEMBL4858508
PubChem CID: 163323742
Max Phase: Preclinical
Molecular Formula: C31H34N6O3
Molecular Weight: 538.65
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCc1nc2c(N)nc3ccccc3c2n1Cc1ccc(CNC(=O)NCCc2ccc(O)c(O)c2)cc1
Standard InChI: InChI=1S/C31H34N6O3/c1-2-3-8-27-36-28-29(23-6-4-5-7-24(23)35-30(28)32)37(27)19-22-11-9-21(10-12-22)18-34-31(40)33-16-15-20-13-14-25(38)26(39)17-20/h4-7,9-14,17,38-39H,2-3,8,15-16,18-19H2,1H3,(H2,32,35)(H2,33,34,40)
Standard InChI Key: XIUYQOKKDQPUCV-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.65Molecular Weight (Monoisotopic): 538.2692AlogP: 5.01#Rotatable Bonds: 10Polar Surface Area: 138.32Molecular Species: NEUTRALHBA: 7HBD: 5#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 9.29CX Basic pKa: 4.87CX LogP: 5.08CX LogD: 5.08Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.16Np Likeness Score: -0.75
References 1. Kimani FW, Manna S, Moser B, Shen J, Nihesh N, Esser-Kahn AP.. (2021) Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators., 12 (9.0): [PMID:34527180 ] [10.1021/acsmedchemlett.1c00267 ]